Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

Item
http://www.wikidata.org/entity/Q37651875
Older patients with myeloma derive similar benefit from autologous transplantation.How we manage autologous stem cell transplantation for patients with multiple myelomaRehabilitation referrals and outcomes in the early period after hematopoietic cell transplantation.Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Autologous haematopoietic cell transplantation in elderly patients with multiple myeloma.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia.
P2860

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

Item
http://www.wikidata.org/entity/Q37651875
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@en
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@nl
type
label
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@en
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@nl
prefLabel
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@en
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Hematopoietic cell transplant ...... lantation in multiple myeloma.
@en
P2093
P2860
P304
P31
P356
10.1016/J.BBMT.2013.12.557
P433
P478
P50
P577
P5875
P698
P932